A. de Jonge

Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors.

H. N. Doods, M. J. Mathy, D. Davidesko et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 441 citations

Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat.

J C van Meel, A. de Jonge, P.B.M.W.M. Timmermans et al. · Journal of Pharmacology and Experimental Therapeutics · 1981 · 200 citations

Molecular Pharmacology, Functional Selectivity, Medicine +6

Vascular smooth muscle contraction initiated by postsynaptic α2-adrenoceptor activation is induced by an influx of extracellular calcium

J. C. A. van Meel, A. de Jonge, Hans O. Kalkman et al. · European Journal of Pharmacology · 1981 · 158 citations

Muscle Physiology, Muscle Function, Molecular Physiology +13

Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic α 2-Adrenoceptors

J. C. A. van Meel, A. de Jonge, Hans O. Kalkman et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1981 · 135 citations

Molecular Pharmacology, Adrenal Gland, Sodium Homeostasis +7

A lipophilic, selective α1 -adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino) imidazolidine (St 587)

A. de Jonge, J. C. A. van Meel, Pieter B.M.W.M. Timmermans et al. · Life Sciences · 1981 · 103 citations

Molecular Pharmacology, Biochemistry, Medicine +9